A pilot study of proton magnetic spectroscopy in children and adolescents with attention deficit hyperactivity disorder (ADHD) before and after treatment with Oros methylphenidate
Phase of Trial: Phase IV
Latest Information Update: 04 May 2011
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Sep 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 24 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.